FDA grants $1.2m for graphene safety and toxicity research

The U.S Food and Drug Administration (FDA) announced a $1.2m grant for the Arkansas Research Alliance (ARA) to extend a collaborative research program focused on graphene-based nanomaterials.

The ARA stated that the research will be focused primarily on the safety and toxicity of graphene and its impact on public health. This project will be a collaborative effort between the ARA and the National Center for Toxicological Research (NCTR), the FDA's primary research facility. Four research universities will also take part in the research.

Source: 
Posted: Dec 18,2014 by Roni Peleg